Preliminary analysis of immune responses in patients enrolled in a Phase II trial of cyclophosphamide with allogenic dribble vaccine alone (DPV-001) or with GM-CSF or imiquimod for adjuvant treatment of stage IIIa or IIIb NSCLC

Mostrar otras versiones (1)
Detalles Bibliográficos
Autores principales: Sanborn, Rachel, Boulmay, Brian, Li, Rui, Spieler, Bradley, Happel, Kyle, Paustian, Christopher, Mougdil, Tarsem, Feng, Zipei, Dubay, Christopher, Fisher, Brenda, Koguchi, Yoshinobu, Aung, Sandra, Mederos, Eileen, Bifulco, Carlo, McNamara, Michael, Bahjat, Keith S, Redmond, William, Ochoa, Augusto C, Hu, Hong Ming, Fox, Bernard, Urba, Walter, Hilton, Traci
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Poster Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4652497/
http://dx.doi.org/10.1186/2051-1426-3-S2-P435
Mostrar todas las versiones(2)

Ejemplares similares